John C. Roche's most recent trade in Hanover Insurance Group Inc was a trade of 122 Common Stock done . Disclosure was reported to the exchange on June 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2026 | 122 | 141,132 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 193.79 per share. | 19 May 2026 | 24,766 | 149,368 (0%) | 0% | 193.8 | 4,799,403 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 104.11 per share. | 19 May 2026 | 24,026 | 174,134 (0%) | 0% | 104.1 | 2,501,347 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2026 | 24,026 | 48,052 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.87 per share. | 19 May 2026 | 9,098 | 150,108 (0%) | 0% | 85.9 | 781,245 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2026 | 9,098 | 0 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 194.05 per share. | 19 May 2026 | 5,145 | 141,071 (0%) | 0% | 194.0 | 998,387 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 193.21 per share. | 19 May 2026 | 3,152 | 146,216 (0%) | 0% | 193.2 | 608,998 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 194.77 per share. | 19 May 2026 | 61 | 141,010 (0%) | 0% | 194.8 | 11,881 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.87 per share. | 15 May 2026 | 18,194 | 159,204 (0%) | 0% | 85.9 | 1,562,319 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2026 | 18,194 | 9,098 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.64 per share. | 15 May 2026 | 12,943 | 146,261 (0%) | 0% | 194.6 | 2,519,226 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 198.65 per share. | 15 May 2026 | 2,516 | 141,110 (0%) | 0% | 198.6 | 499,803 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 197.61 per share. | 15 May 2026 | 2,260 | 143,626 (0%) | 0% | 197.6 | 446,599 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 196.55 per share. | 15 May 2026 | 375 | 145,886 (0%) | 0% | 196.5 | 73,706 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 199.23 per share. | 15 May 2026 | 100 | 141,010 (0%) | 0% | 199.2 | 19,923 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2026 | 152 | 141,010 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2025 | 134 | 123,849 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 185.91 per share. | 01 Dec 2025 | 382 | 123,714 (0%) | 0% | 185.9 | 71,018 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2025 | 590 | 124,096 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2025 | 132 | 124,686 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2025 | 140 | 124,554 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 01 Apr 2025 | 8,906 | 133,319 (0%) | 0% | 77.9 | 693,866 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.17 per share. | 01 Apr 2025 | 8,906 | 124,413 (0%) | 0% | 175.2 | 1,560,064 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 8,906 | 0 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 28 Mar 2025 | 400 | 124,677 (0%) | 0% | 77.9 | 31,164 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 400 | 9,207 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.03 per share. | 28 Mar 2025 | 400 | 124,277 (0%) | 0% | 175.0 | 70,012 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Mar 2025 | 301 | 8,906 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.00 per share. | 28 Mar 2025 | 301 | 124,413 (0%) | 0% | 175 | 52,675 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 28 Mar 2025 | 301 | 124,714 (0%) | 0% | 77.9 | 23,451 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2025 | 135 | 124,413 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 26 Mar 2025 | 900 | 125,177 (0%) | 0% | 77.9 | 70,119 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 900 | 9,807 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.17 per share. | 26 Mar 2025 | 900 | 124,277 (0%) | 0% | 175.2 | 157,653 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2025 | 200 | 9,607 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 175.01 per share. | 26 Mar 2025 | 200 | 124,277 (0%) | 0% | 175.0 | 35,002 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 26 Mar 2025 | 200 | 124,477 (0%) | 0% | 77.9 | 15,582 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 10,706 | 10,707 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.91 per share. | 03 Mar 2025 | 10,706 | 134,983 (0%) | 0% | 77.9 | 834,104 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 172.66 per share. | 03 Mar 2025 | 5,509 | 124,277 (0%) | 0% | 172.7 | 951,184 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 171.86 per share. | 03 Mar 2025 | 3,303 | 129,786 (0%) | 0% | 171.9 | 567,654 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 170.91 per share. | 03 Mar 2025 | 1,894 | 133,089 (0%) | 0% | 170.9 | 323,704 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2025 | 22,943 | 0 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.14 per share. | 27 Feb 2025 | 22,943 | 148,707 (0%) | 0% | 66.1 | 1,517,450 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.00 per share. | 27 Feb 2025 | 15,604 | 133,103 (0%) | 0% | 166 | 2,590,264 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 170.53 per share. | 27 Feb 2025 | 8,826 | 124,277 (0%) | 0% | 170.5 | 1,505,098 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 39,629 | 39,629 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 9,554 | 115,368 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 8,652 | 125,764 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 1,744 | 117,112 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | C. John Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2024 | 143 | 105,814 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.52 per share. | 02 Dec 2024 | 412 | 105,671 (0%) | 0% | 162.5 | 66,958 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 05 Nov 2024 | 6,802 | 14,454 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Other type of transaction at price $ 0.00 per share. | 05 Nov 2024 | 6,802 | 107,108 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Nov 2024 | 1,025 | 106,083 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2024 | 143 | 113,910 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 167 | 113,766 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 153 | 113,599 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | Roche John C. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 41,437 | 41,437 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | Roche C. John | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.61 per share. | 26 Feb 2024 | 11,233 | 104,135 (0%) | 0% | 134.6 | 1,512,074 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 9,311 | 113,446 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | C. John Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 9,120 | 109,045 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2024 | 6,322 | 115,367 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John Roche C. | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 22,305 | 0 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 54.61 per share. | 16 Feb 2024 | 22,305 | 113,978 (0%) | 0% | 54.6 | 1,218,076 | Common Stock |
| Hanover Insurance Grp Inc | C. Roche John | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 135.88 per share. | 16 Feb 2024 | 14,053 | 99,925 (0%) | 0% | 135.9 | 1,909,522 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 162 | 91,673 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | C. John Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.09 per share. | 01 Dec 2023 | 686 | 91,511 (0%) | 0% | 125.1 | 85,812 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 173 | 92,197 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 168 | 92,024 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 147 | 91,855 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 36,453 | 36,453 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.48 per share. | 27 Feb 2023 | 10,017 | 91,708 (0%) | 0% | 139.5 | 1,397,171 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 8,822 | 87,042 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 8,214 | 101,725 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2023 | 6,469 | 93,511 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 24 Feb 2023 | 6,336 | 81,546 (0%) | 0% | 40.0 | 253,503 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 6,336 | 0 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.34 per share. | 24 Feb 2023 | 3,326 | 78,220 (0%) | 0% | 139.3 | 463,445 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2022 | 130 | 75,210 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 127 | 75,079 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 109 | 74,952 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 155.24 per share. | 21 Apr 2022 | 922 | 74,843 (0%) | 0% | 155.2 | 143,133 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 922 | 6,336 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 21 Apr 2022 | 922 | 75,765 (0%) | 0% | 40.0 | 36,889 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 4,533 | 9,983 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 150.09 per share. | 25 Mar 2022 | 4,533 | 74,843 (0%) | 0% | 150.1 | 680,355 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 25 Mar 2022 | 4,533 | 79,376 (0%) | 0% | 40.0 | 181,365 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2022 | 2,725 | 7,258 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 150.47 per share. | 25 Mar 2022 | 2,725 | 74,843 (0%) | 0% | 150.5 | 410,042 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 25 Mar 2022 | 2,725 | 77,568 (0%) | 0% | 40.0 | 109,027 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2022 | 107 | 74,843 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2022 | 7,258 | 14,516 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.01 per share. | 17 Mar 2022 | 7,258 | 81,993 (0%) | 0% | 40.0 | 290,393 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 145.65 per share. | 17 Mar 2022 | 6,193 | 75,800 (0%) | 0% | 145.7 | 902,017 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 146.21 per share. | 17 Mar 2022 | 1,065 | 74,735 (0%) | 0% | 146.2 | 155,713 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 139.52 per share. | 07 Mar 2022 | 7,565 | 74,735 (0%) | 0% | 139.5 | 1,055,469 | Common Stock |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 34,689 | 34,689 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 8,685 | 70,337 (0%) | 0% | 0 | Common Stock | |
| Hanover Insurance Grp Inc | John C. Roche | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 7,097 | 82,299 (0%) | 0% | 0 | Common Stock |